Payment overview · 2025
General Payments
$171.11
10 reported records · 4 companies
Healthcare provider profile · identity verified
Donald Grant Guild, MD
Allopathic & Osteopathic Physicians|Family Medicine · PHILADELPHIA, MS · NPI 1255654778
Verified facts
What the public records show
CMS Open Payments records show Donald Grant Guild, MD received $171.11 in general payments during 2025 across 10 reported records.
Bayer Healthcare Pharmaceuticals Inc. accounted for 44.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 5 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | Unresolved — no canonical attribution shown | $75.29 | 44.0% | 4 | 2025 |
| Paratek Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $42.85 | 25.0% | 3 | 2025 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | Unresolved — no canonical attribution shown | $34.71 | 20.3% | 2 | 2025 |
| Stryker Corporation | Unresolved — no canonical attribution shown | $18.26 | 10.7% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $171.11 | 10 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Kerendia Normalized: kerendia |
Drug | Bayer Healthcare Pharmaceuticals Inc. | $75.29 | 4 | 2025 |
Source payment records
|
|||||
| NUZYRA Normalized: nuzyra |
Drug | Paratek Pharmaceuticals, Inc. | $42.85 | 3 | 2025 |
Source payment records
|
|||||
| CAPLYTA Normalized: caplyta |
Drug | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $34.71 | 2 | 2025 |
Source payment records
|
|||||
| CT THROMBECTOMY SYSTEM KIT Normalized: ct thrombectomy system kit |
Device | Stryker Corporation | $18.26 | 1 | 2025 |
Source payment records
|
|||||
| FLOWTRIEVER CATHETER, S Normalized: flowtriever catheter s |
Device | Stryker Corporation | $18.26 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 360 | 66 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 349 | 91 |
| Potassium Chloride | Potassium Chloride | 341 | 88 |
| Omeprazole | Omeprazole | 327 | 87 |
| Furosemide | Furosemide | 326 | 75 |
| Gabapentin | Gabapentin | 323 | 82 |
| Amlodipine Besylate | Amlodipine Besylate | 322 | 90 |
| Atorvastatin Calcium | Atorvastatin Calcium | 302 | 85 |
| Metformin Hcl | Metformin Hcl | 259 | 64 |
| Eliquis | Apixaban | 233 | 35 |
| Lisinopril | Lisinopril | 223 | 55 |
| Donepezil Hcl | Donepezil Hcl | 190 | 36 |
| Meloxicam | Meloxicam | 182 | 52 |
| Pantoprazole Sodium | Pantoprazole Sodium | 169 | 50 |
| Metoprolol Succinate | Metoprolol Succinate | 167 | 43 |
| Trazodone Hcl | Trazodone Hcl | 167 | 38 |
| Losartan Potassium | Losartan Potassium | 159 | 44 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 153 | 35 |
| Memantine Hcl | Memantine Hcl | 143 | 24 |
| Sertraline Hcl | Sertraline Hcl | 141 | 27 |
| Escitalopram Oxalate | Escitalopram Oxalate | 139 | 24 |
| Carvedilol | Carvedilol | 131 | 35 |
| Tamsulosin Hcl | Tamsulosin Hcl | 128 | 28 |
| Montelukast Sodium | Montelukast Sodium | 122 | 33 |
| Clopidogrel | Clopidogrel Bisulfate | 121 | 32 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 118 | 41 |
| Metoprolol Tartrate | Metoprolol Tartrate | 118 | 31 |
| Ozempic | Semaglutide | 108 | 22 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 97 | 72 |
| Tizanidine Hcl | Tizanidine Hcl | 94 | 26 |
| Spironolactone | Spironolactone | 92 | 33 |
| Alprazolam | Alprazolam | 90 | 17 |
| Citalopram Hbr | Citalopram Hydrobromide | 89 | 15 |
| Pravastatin Sodium | Pravastatin Sodium | 88 | 19 |
| Jardiance | Empagliflozin | 87 | 13 |
| Quetiapine Fumarate | Quetiapine Fumarate | 87 | 12 |
| Doxycycline Hyclate | Doxycycline Hyclate | 86 | 52 |
| Mirtazapine | Mirtazapine | 86 | 14 |
| Hydrochlorothiazide | Hydrochlorothiazide | 83 | 27 |
| Clonidine Hcl | Clonidine Hcl | 81 | 27 |
| Xarelto | Rivaroxaban | 81 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 77 | 16 |
| Simvastatin | Simvastatin | 77 | 15 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 76 | 23 |
| Famotidine | Famotidine | 73 | 13 |
| Tramadol Hcl | Tramadol Hcl | 73 | 20 |
| Allopurinol | Allopurinol | 72 | 19 |
| Clonazepam | Clonazepam | 69 | 19 |
| Fluticasone Propionate | Fluticasone Propionate | 69 | 22 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 62 | 20 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 59 | 15 |
| Olanzapine | Olanzapine | 59 | 12 |
| Hydralazine Hcl | Hydralazine Hcl | 58 | 13 |
| Prednisone | Prednisone | 58 | 25 |
| Mounjaro | Tirzepatide | 57 | suppressed |
| Azithromycin | Azithromycin | 54 | 46 |
| Farxiga | Dapagliflozin Propanediol | 54 | 17 |
| Buspirone Hcl | Buspirone Hcl | 51 | suppressed |
| Mupirocin | Mupirocin | 50 | 29 |
| Ondansetron Hcl | Ondansetron Hcl | 49 | 21 |
| Duloxetine Hcl | Duloxetine Hcl | 48 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 47 | 32 |
| Glipizide | Glipizide | 47 | 17 |
| Lactulose | Lactulose | 47 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 43 | 12 |
| Baclofen | Baclofen | 42 | 11 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 42 | suppressed |
| Pregabalin | Pregabalin | 41 | 18 |
| Zolpidem Tartrate | Zolpidem Tartrate | 41 | 12 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 40 | 12 |
| Levetiracetam | Levetiracetam | 40 | suppressed |
| Linzess | Linaclotide | 40 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 40 | suppressed |
| Lovastatin | Lovastatin | 39 | 11 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 39 | suppressed |
| Glipizide Er | Glipizide | 38 | 11 |
| Sucralfate | Sucralfate | 37 | suppressed |
| Glimepiride | Glimepiride | 36 | 11 |
| Januvia | Sitagliptin Phosphate | 36 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 34 | 12 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 34 | 21 |
| Theophylline Er | Theophylline Anhydrous | 34 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 33 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 33 | suppressed |
| Ezetimibe | Ezetimibe | 32 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 31 | suppressed |
| Invokana | Canagliflozin | 31 | suppressed |
| Novolin R Flexpen | Insulin Regular, Human | 31 | suppressed |
| Ondansetron Odt | Ondansetron | 31 | 15 |
| Digoxin | Digoxin | 30 | suppressed |
| Finasteride | Finasteride | 30 | 11 |
| Fluconazole | Fluconazole | 30 | 26 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 29 | suppressed |
| Lokelma | Sodium Zirconium Cyclosilicate | 29 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 29 | suppressed |
| Latanoprost | Latanoprost | 28 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 27 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 27 | 11 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 27 | 11 |
| Novolin R | Insulin Regular, Human | 27 | suppressed |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 27 | 27 |
| Risperidone | Risperidone | 27 | suppressed |
| Temazepam | Temazepam | 27 | suppressed |
| Trulicity | Dulaglutide | 27 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 26 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 26 | 12 |
| Tresiba Flextouch U-200 | Insulin Degludec | 26 | suppressed |
| Methocarbamol | Methocarbamol | 25 | 11 |
| Metronidazole | Metronidazole | 25 | 20 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 24 | 18 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 24 | suppressed |
| Levofloxacin | Levofloxacin | 24 | 21 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 24 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 24 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 24 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 23 | suppressed |
| Celecoxib | Celecoxib | 23 | suppressed |
| Diazepam | Diazepam | 23 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 23 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 23 | suppressed |
| Naproxen | Naproxen | 23 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 22 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 22 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 22 | suppressed |
| Estradiol | Estradiol | 21 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 21 | suppressed |
| Cilostazol | Cilostazol | 20 | suppressed |
| Irbesartan | Irbesartan | 20 | suppressed |
| Nifedipine Er | Nifedipine | 20 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 20 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 19 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 19 | suppressed |
| Chlorthalidone | Chlorthalidone | 19 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 19 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 18 | 12 |
| Methylprednisolone | Methylprednisolone | 18 | 14 |
| Tradjenta | Linagliptin | 18 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 17 | suppressed |
| Lorazepam | Lorazepam | 17 | suppressed |
| Nitroglycerin | Nitroglycerin | 17 | 12 |
| Sodium Chloride | 0.9 % Sodium Chloride | 17 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 17 | suppressed |
| Vraylar | Cariprazine Hcl | 17 | suppressed |
| Acyclovir | Acyclovir | 16 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 16 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 16 | suppressed |
| Gentamicin Sulfate | Gentamicin Sulfate | 16 | 11 |
| Glyburide | Glyburide | 16 | suppressed |
| Novolog | Insulin Aspart | 16 | suppressed |
| Nystatin | Nystatin | 16 | 11 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 16 | suppressed |
| Tamoxifen Citrate | Tamoxifen Citrate | 16 | suppressed |
| Valsartan | Valsartan | 16 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 16 | suppressed |
| Xifaxan | Rifaximin | 16 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 15 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 15 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 15 | suppressed |
| Myrbetriq | Mirabegron | 15 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 15 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 14 | suppressed |
| Bydureon Bcise | Exenatide Microspheres | 14 | suppressed |
| Cephalexin | Cephalexin | 14 | suppressed |
| Humulin R | Insulin Regular, Human | 14 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 14 | suppressed |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 14 | suppressed |
| Rexulti | Brexpiprazole | 14 | suppressed |
| Carbamazepine | Carbamazepine | 13 | suppressed |
| Cefdinir | Cefdinir | 13 | 12 |
| Fentanyl | Fentanyl | 13 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 13 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 13 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 13 | suppressed |
| Atenolol | Atenolol | 12 | suppressed |
| Atropine Sulfate | Atropine Sulfate | 12 | suppressed |
| Clorazepate Dipotassium | Clorazepate Dipotassium | 12 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 12 | suppressed |
| Dexamethasone Sodium Phosphate | Dexamethasone Sodium Phosphate | 12 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 12 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 12 | suppressed |
| Imiquimod | Imiquimod | 12 | suppressed |
| Levemir Flexpen | Insulin Detemir | 12 | suppressed |
| Metolazone | Metolazone | 12 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 12 | suppressed |
| Topiramate | Topiramate | 12 | suppressed |
| Verapamil Er | Verapamil Hcl | 12 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 12 | suppressed |
| Amoxicillin | Amoxicillin | 11 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 11 | suppressed |
| Phenytoin | Phenytoin | 11 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $171.11 · 10 records | Bayer Healthcare Pharmaceuticals Inc. | CAPLYTA, CT THROMBECTOMY SYSTEM KIT, FLOWTRIEVER CATHETER, S, Kerendia, NUZYRA | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error